USPTO serial 79303432
DEXPLORER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 22, 2022
- Examiner
- NOVAKOVIC, MIROSLAV
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DEXPLORER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh Ann Lindquist
Leigh Ann Lindquist SUGHRUE MION, PLLC2000 Pennsylvania Avenue NW, Suite 9000Washington, DC 20006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Recorded computer software for drug development using artificial intelligence; recorded computer software for analytics for clinical trial data, for data collection, data analysis, data storing, data mining, data generation, and machine learning, all in drug discovery and drug development fields; recorded computer software for simulating drug development; recorded computer software for the analysis of data in the medical and biotechnology fields using algorithm for deep learning; recorded computer software based on artificial intelligence for image analysis and data analysis in the medical and biotechnology fields; recorded computer software for analysing medical diagnostic information; computer operating programs, recorded; recorded computer software for data processing; recorded medical software for pregnancy education; recorded medical software for uploading, storing and submitting medical images for computer-aided diagnosis of respiratory medical conditions affecting humans, providing patient diagnosis risk assessments, workflow management and billing in the field of healthcare; recorded medical software for recording, processing, transmitting, and receiving data for medical diagnostic and monitoring purposes; recorded medical software for aiding in the detection and diagnostics of congestive heart failure; recorded software for artificial intelligence conversion, analysis, processing, storage and transmission | ACTIVE | — |
| 042 | Drug discovery services; research for medical products; scientific research and technical consulting on the test, inspection and research of medical products; development of pharmaceutical preparations and medicines; drug discovery services based on artificial intelligence; software design and development; computer software consultancy; application service provider featuring software for local, wide and global communications networks which allow users to connect remote computers and computer networks together to exchange healthcare information and data; software as a service featuring software based on artificial intelligence for the analysis of deep learning image and data in the medical and biotechnology fields; platform as a service featuring computer software platform for data collection, data analysis, data storage and data mining used in the healthcare and biotechnology fields; software as a service featuring software for data collection, data analysis, data storage and data mining used in the healthcare and biotechnology fields; design of computer software for healthcare and medical institutions; installation and maintenance of computer software for healthcare and medical institutions; technical consultation related to medical research, biotechnology data analysis and software development; technical consultation related to medical data analysis for research purposes; technical consultation related to software development in the medical field; research and development of computer software platform in the artificial intelligence field; software development for artificial intelligence service; drug discovery services through computer modeling methods; development of computer software for big data processing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Medicare Pharmaceuticals Inc.
- Other trademarks owned by Medicare Pharmaceuticals Inc.
- Other trademarks owned by Medicare Pharmaceuticals Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named DEXPLORER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 5, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 12, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 11, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 22, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 22, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 4, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 4, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 1, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 15, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 15, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 15, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 2, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 2, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 2, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 2, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 2, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 18, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 18, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 18, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 15, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 15, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 15, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 15, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 13, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 27, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 27, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 25, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 24, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 4, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |